On June 1, Novartis fell 3.06% in regular trading, trading at $144.97/share, with trading volume of $46.1449 million.
Within the Pharmacy sector where Novartis belongs, the overall sector is under pressure. Among individual stocks, Eli Lilly down 2.21%, Johnson & Johnson down 1.49%, Pfizer down 1.93%, Bristol-Myers Squibb down 3.49%, Merck down 2.81%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)